M&A Deal Summary

Duke Street Private Equity Acquires COMPO

On June 3, 2021, private equity firm Duke Street Private Equity acquired chemicals company COMPO from Kingenta

Acquisition Highlights
  • This is Duke Street Private Equity’s 2nd transaction in the Chemicals sector.
  • This is Duke Street Private Equity’s 4th transaction in Germany.

M&A Deal Summary

Date 2021-06-03
Target COMPO
Sector Chemicals
Buyer(s) Duke Street Private Equity
Sellers(s) Kingenta
Deal Type Divestiture

Target

COMPO

Munster, Germany
COMPO provides a wide range of technically superior products under one of the most respected and well-known brands in the industry. Its diverse product portfolio offers retailers and consumers ‘bio’ alternatives to traditional gardening product solutions. COMPO was founded in 1956 and is based in Munster, Germany.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Duke Street Private Equity

London, United Kingdom

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1988
PE ASSETS 3.0B EUR
Size Large
Type Sector Agnostic
DESCRIPTION

Duke Street Private Equity is a European private equity firm that targets investments in mid-market UK and French businesses valued between €50 and €350 million. Duke Street looks to build companies through organic growth and acquisitions. Sectors of interest include business services and outsourcing, retail and consumer, food, industrial, healthcare, leisure, and financial services. Duke Street Private Equity was founded in 1988 and is based in London.


DEAL STATS #
Overall 53 of 56
Sector (Chemicals) 2 of 2
Type (Divestiture) 6 of 7
Country (Germany) 4 of 5
Year (2021) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-06-05 Kent Pharma

Ashford, United Kingdom

Kent Pharma is a provider in the development, manufacture, sales, marketing, and distribution of generic pharmaceuticals for the British, Irish and international markets. Kent has a broad portfolio of its own licensed products with a particular focus on beta lactam antibiotics including penicillin V, flucloxacillin and amoxicillin, which are long established antibiotics typically used to treat bacterial infections such as throat, ear and respiratory tract infections. Kent Pharma was founded in 1986 and is based in Ashford, United Kingdom.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-01-14 Voyage Care

Lichfield, United Kingdom

Voyage Care provides specialist care and support to people with learning and physical difficulties, brain injuries, autism, and other complex needs across the UK. Voyage Care was founded in 1988 and is based in Lichfield, United Kingdom.

Sell -

Seller(S) 1

SELLER

Kingenta

Linyi, China

Category Company
Founded 1998
Sector Chemicals
Employees6,220
Revenue 8.5B CNY (2023)
DESCRIPTION

Kingenta is a provider in the research and development, production, and sales of a full range of products required for soil such as compound fertilizers, slow and controlled release fertilizers, nitro fertilizers, water-soluble fertilizers, biological fertilizers, and soil conditioners. Kingenta was founded in 1998 and is based in Linyi, China.


DEAL STATS #
Overall 1 of 1
Sector (Chemicals) 1 of 1
Type (Divestiture) 1 of 1
Country (Germany) 1 of 1
Year (2021) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-06-30 COMPO

Munster, Germany

COMPO provides a wide range of technically superior products under one of the most respected and well-known brands in the industry. Its diverse product portfolio offers retailers and consumers ‘bio’ alternatives to traditional gardening product solutions. COMPO was founded in 1956 and is based in Munster, Germany.

Buy -